Effects of Caregiver Dementia Training in Caregiver–Patient Dyads on Psychotropic Drug Prescription: A Randomized Controlled Study

Figures & data

Table 1 Number (and Percentage) of Participants Using Psychotropic Medication Use of the Intervention and Control Group at Baseline and After Three Months Including the Difference Between the Intervention and Control Value at Three Months in p-value, Chi Square Value, Mean Difference and 95% Confidence Interval

	baseline		three months
Person with dementia	Interven-tion n= 59	control n=46	Interven-tion n= 49	control n= 39	p^a	X^2 value^b	MD^c	95% CI^d
All psychotropic drugs	9 (15)^e	11 (24)	8 (16)	8 (21)	0.61	1.26	0.04	-0.12 – 0.21
Antipsychotics	3 (5)	2 (4)	2 (4)	1 (3)	0.70	0.15	-0.02	-0.09 – 0.06
Antidepressants	7 (12)	8 (17)	7 (14)	6 (15)	0.89	0.02	0.01	-0.14 - 0.17
Hypnotics and anxiolytics	1 (2)	1 (2)	1 (2)	1 (3)	0.87	0.27	0.01	-0.06 – 0.07
Caregiver	n=59	n=48	n=48	n=40
All psychotropic drugs	12 (20)	7 (1)	6 (13)	2 (5)	0.22	1.49	-0.08	-0.20 – 0.05
Antipsychotics	2 (3)	0	1 (2)	0	0.36	0.84	-0.02	-0.07 – 0.03
Antidepressants	6 (10)	4 (8)	3 (6)	1 (3)	0.40	0.71	-0.04	0.13 – 0.05
Hypnotics and anxiolytics	6 (10)	4 (8)	2 (4)	1 (3)	0.67	0.18	-0.02	-0.10 – 0.06

Notes: ^ap, p-value; ^bx² value, Pearson Chi Square; ^cMD, mean difference; ^dCI, confidence intervals; ^epercentage between parenthesis.